CRIS Q1 2020 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+53.3% YoY

Gross Profit

$3M95.4% margin

Operating Income

-$8M-313.1% margin

Net Income

-$10M-358.4% margin

EPS (Diluted)

$-5.64

QoQ Revenue Growth

-17.6%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$625,000

Balance Sheet

Total Assets

$27M

Total Liabilities

$67M

Stockholders' Equity

-$40M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+53.3%
Gross Profit	$3M	$2M	+55.8%
Operating Income	-$8M	-$6M	-52.6%
Net Income	-$10M	-$10M	+1.8%

Revenue Segments

Gross Royalty Revenue

$3M93%

Other Revenue

$211,0008%

Contra Revenue

-$17,000-1%